1. First-line therapy for CML: decisions, decisions. Issue 3 (March 2015) Authors: Davies, Jeff Journal: Lancet Issue: Volume 2:Issue 3(2015) Page Start: e89 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Pre-market version of a commercially available hearing instrument with a tinnitus sound generator: feasibility of evaluation in a clinical trial. (3rd April 2017) Authors: Sereda, Magdalena; Davies, Jeff; Hall, Deborah A. Journal: International journal of audiology Issue: Volume 56:Number 4(2017) Page Start: 286 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Reduced intensity allogeneic hematopoietic stem cell transplantation is a safe and effective treatment option in high‐risk myeloma patients – a single centre experience. (13th March 2021) Authors: Jurgensen‐Rauch, Amanda; Gibbs, Suzanne; Farrell, Maresa; Aries, James; Grantham, Marianne; Eccersley, Lydia; Gribben, John; Hallam, Simon; Oakervee, Heather; Cavenagh, Jamie; Davies, Jeff; Sive, Jonathan Journal: British journal of haematology Issue: Volume 193:Number 2(2021) Page Start: 420 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Review of 'Personalized Immunosuppression in Transplantation' Edited by MichaelOellerich and AmitavaDasgupta. (February 2017) Authors: Davies, Jeff Journal: British journal of haematology Issue: Volume 176:Number 3(2017) Page Start: 502 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗